Steven J. Mento

Steven J. Mento discloses dealings in 2 companies, chiefly Sangamo Therapeutics, Inc and Histogen Inc. The record holds 15 filings, for trades running from 20 December 2016 to 22 May 2020.

Sales make up the whole of the open-market record (4 sales, €479k). The rest of the record consists of 2 share grants and 9 option exercises.

The latest filing, published on 27 May 2020, reports a share grant of €16k in Histogen Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.